ZKSCAN3 and gastric cancer: Clinicopathologic analysis showed that 32.2% of gastric cancer samples had abnormally high expression of ZKSCAN3, and the intensity of its expression was significantly and positively correlated with lymphatic metastasis and distant dissemination.